Clinical trial

Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy

NCT03186742

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-07-01

PhasePHASE4

Study timeline

Study start (actual)2014-07-01Date precision: day

Registry last updated2017-06-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertension,Essentialunresolved

Obstructive Sleep Apneaunresolved

Left Ventricular Hypertrophyunresolved

Interventions

Eplerenone 50 mg TabDRUG

Sponsors & collaborators

Poznan University of Medical Scienceslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03186742 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.